Serum Institute Seeks Protection Against Liabilities Related To Covishield Vaccine
Pune, 3rd June 2021: Serum Institute of India, which manufactures AstraZeneca’s Vaccine Covishield in India, has sought legal protection from any compensation or compensation claims for adverse events related to its vaccine. There is speculation that the Indian government may give such protection to foreign companies like Pfizer and Moderna.
In fact, in view of the increasing cases of corona in India, the government has tied up with many foreign vaccine manufacturers. However, a legal issue seemed to be stuck. American companies Pfizer and Moderna had demanded the Indian government to give it legal protection from any claim related to the use of their Covid-19 vaccine. According to reports, the Indian government had also agreed to this. Now Serum Institute has also demanded similar protection regarding its vaccine.
Earlier India’s drug regulatory body i.e. Drugs Controller General of India (DCGI) had removed the conditions for conducting separate local trials of foreign vaccines like Pfizer and Moderna to bring them to India as soon as possible. According to the new rules, if a vaccine has received emergency use approval from the drug regulatory body of major countries or the World Health Organization (WHO), it will not have to undergo a separate trial in India.
